This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Coping with unexpected personal finance challenges involves rapid assessment, prioritizing essentials, and building a short-term recovery plan you can follow.
15,854 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Tech Mahindra's Mohit Joshi says AI will transform jobs, not vanish them. This piece surveys how IT services leaders ...
When oil prices spike, the market story often shifts. This piece uses prices skyrocketing years history to explore wh...
The Treasury issued a general license for energy aboard vessels, unlocking up to 140 million barrels. Markets weigh t...
Wall Street leaned on a familiar Fed playbook for years. Now a surprising pivot in that script could rattle stocks an...
Delek US shares jumped as crude and refining margins strengthened. This article breaks down the drivers, the risks, a...
Could investing $10,000 walmart really boost your wealth? This guide dives into Walmart's growth story, realistic ret...
After years of outsized gains, the magnificent seven faces a pullback. This guide explains how to evaluate the dip, p...
Federal safety regulators announce a recall of about 12,830 toddler tower stools across three brands after dozens of ...
As housing markets shift, investors wonder if Opendoor can deliver a meaningful stock reaction by 2026. This guide br...
Airbnb (ABNB) enters 2026 with evolving monetization and travel demand. This guide breaks down Q1 insights, margins, ...
The Nasdaq led a tech-led rally as AI demand and solid jobs data improved sentiment. This analysis breaks down what m...